Metastatic Urothelial Carcinoma Clinical Trials in New York, New York
2 recruitingNew York, New York
Showing 1–2 of 2 trials
Recruiting
Phase 1
Pembrolizumab Plus CA-4948 for the Treatment of Patients With Progressive Metastatic Urothelial Cancer Despite Prior Immunotherapy
Metastatic Urothelial CarcinomaUnresectable Urothelial Carcinoma
National Cancer Institute (NCI)27 enrolled11 locationsNCT06439836
Recruiting
A Study of Neuropathy Caused by Enfortumab Vedotin in People With Urothelial Carcinoma
Urothelial CarcinomaMetastatic Urothelial CarcinomaNeuropathy
Memorial Sloan Kettering Cancer Center50 enrolled7 locationsNCT07390617